Role of response gene to complement 32 in diseases

Archivum Immunologiae et Therapiae Experimentalis

Volumn 56, Issue 2, 2008, Pages 115-122

  Vlaicu, Sonia I ^a   Cudrici, Cornelia ^a   Ito, Takahiro ^a   Fosbrink, Matthew ^a   Tegla, Cosmin A ^a   Rus, Violeta ^a   Mircea, Petru A ^a   Rus, Horea ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer; cdc2; Cell cycle; Differentiation; RGC 32

Indexed keywords

COMPLEMENT MEMBRANE ATTACK COMPLEX; CYCLIN DEPENDENT KINASE 1; GENE PRODUCT; GROWTH FACTOR; PROTEIN RGC32; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; SMAD PROTEIN; UNCLASSIFIED DRUG;

BREAST CANCER; CELL CYCLE; CELL CYCLE S PHASE; CELL DIFFERENTIATION; COLON CANCER; CUTANEOUS T CELL LYMPHOMA; DOWN REGULATION; FIBROSIS; GENE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE FUNCTION; GLIOBLASTOMA; HUMAN; HYPER IGE SYNDROME; INFLAMMATION; MITOSIS; MULTIPLE MYELOMA; OVARY CANCER; PATHOGENESIS; PROSTATE CANCER; PROTEIN EXPRESSION; RESPONSE GENE TO COMPLEMENT 32; REVIEW; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; UPREGULATION;

ANIMALS; CELL CYCLE PROTEINS; CELL DIFFERENTIATION; CELL PROLIFERATION; CORTICOSTERONE; ESTRADIOL; FIBROSIS; HUMANS; IMMUNITY; MUSCLE PROTEINS; NEOPLASMS; NERVE TISSUE PROTEINS; REGENERATION;

EID: 42349106471     PISSN: 0004069X     EISSN: 16614917     Source Type: Journal    
DOI: 10.1007/s00005-008-0016-3     Document Type: Review

References (54)

1. Almon R. R., DuBois D. C., Piel W. H. and Jusko W. J. (2004): The genomic response of skeletal muscle to methylprednisolone using microarrays: tailoring data mining to the structure of the pharmacogenomic time series. Pharmacogenomics, 5, 525-552.
2. Almon R. R., Lai W., DuBois D. C. and Jusko W. J. (2005): Corticosteroid-regulated genes in rat kidney: mining time series array data. Am. J. Physiol. Endocrinol. Metab., 289, E870-882.
3. Badea T., Niculescu F., Soane L., Fosbrink M., Sorana H., Rus V., Shin M. L. and Rus H. (2002): RGC-32 increases p34CDC2 kinase activity and entry of aortic smooth muscle cells into S-phase. J. Biol. Chem., 277, 502-508.
4. Badea T. C., Niculescu F. I., Soane L., Shin M. L. and Rus H. (1998): Molecular cloning and characterization of RGC-32, a novel gene induced by complement activation in oligodendrocytes. J. Biol. Chem., 273, 26977-26981.
5. Balagopal P., Olney R., Darmaun D., Mougey E., Dokler M., Sieck G. and Hammond D. (2006): Oxandrolone enhances skeletal muscle myosin synthesis and alters global gene expression profile in Duchenne muscular dystrophy. Am. J. Physiol. Endocrinol. Metab., 290, E530-539.
6. Blaxall B. C., Tschannen-Moran B. M., Milano C. A. and Koch W. J. (2003): Differential gene expression and genomic patient stratification following left ventricular assist device support. J. Am. Coll. Cardiol., 41, 1096-1106.
7. Bredel M., Bredel C., Juric D., Duran G. E., Yu R. X., Harsh G. R., Vogel H., Recht L. D., Scheck A. C. and Sikic B. I. (2006): Tumor necrosis factor-alpha-induced protein 3 as a putative regulator of nuclear factor-kappaB-mediated resistance to O6-alkylating agents in human glioblastomas. J. Clin. Oncol., 24, 274-287.
8. Burney R. O., Talbi S., Hamilton A. E., Vo K. C., Nyegaard M., Nezhat C. R., Lessey B. A. and Giudice L. C. (2007): Gene expression analysis of endometrium reveals progesterone resistance and candidate susceptibility genes in women with endometriosis. Endocrinology, 145, 3824-3826.
9. Chandran U. R., Ma C., Dhir R., Bisceglia M., Lyons-Weiler M., Liang W., Michalopoulos G., Becich M. and Monzon F. A. (2007): Gene expression profiles of prostate cancer reveal involvement of multiple molecular pathways in the metastatic process. BMC Cancer, 7, 64.
10. Chen Q. M., Alexander D., Sun H., Xie L., Lin Y., Terrand J., Morrissy S. and Purdom S. (2005): Corticosteroids inhibit cell death induced by doxorubicin in cardiomyocytes: induction of antiapoptosis, antioxidant, and detoxification genes. Mol. Pharmacol., 67, 1861-1873.
11. Chen Y., Dokmanovic M., Stein W. D., Ardecky R. J. and Roninson I. B. (2006): Agonist and antagonist of retinoic acid receptors cause similar changes in gene expression and induce senescence-like growth arrest in MCF-7 breast carcinoma cells. Cancer Res., 66, 8749-8761.
12. Dassen H., Punyadeera C., Kamps R., Klomp J., Dunselman G., Dijcks F., de Goeij A., Ederveen A. and Groothuis P. (2007): Progesterone regulation of implantation-related genes: new insights into the role of oestrogen. Cell Mol. Life Sci., 64, 1009-1032.
13. Donninger H., Bonome T., Radonovich M., Pise-Masison C. A., Brady J., Shih J. H., Barrett J. C. and Birrer M. J. (2004): Whole genome expression profiling of advance stage papillary serous ovarian cancer reveals activated pathways. Oncogene, 23, 8065-8077.
14. Esson D. W., Popp M. P., Liu L., Schultz G. S. and Sherwood M. B. (2004): Microarray analysis of the failure of filtering blebs in a rat model of glaucoma filtering surgery. Invest. Ophthalmol. Vis. Sci., 45, 4450-4462.
15. Fosbrink M., Badea T., Shin M. L. and Rus H. (2003): Regulation of RGC-32 mRNA expression by terminal complement complex C5b-9 and growth factors. FASEB J., 17, 323.
16. Fosbrink M., Cudrici C., Niculescu F., Badea T. C., David S., Shamsuddin A., Shin M. L. and Rus H. (2005): Overexpression of RGC-32 in colon cancer and other tumors. Exp. Mol. Pathol., 78, 116-122.
17. Fujimoto N., Igarashi K., Kanno J., Honda H. and Inoue T. (2004): Identification of estrogen-responsive genes in the GH3 cell line by cDNA microarray analysis. J. Steroid Biochem. Mol. Biol., 91, 121-129.
18. Gnainsky Y., Kushnirsky Z., Bilu G., Hagai Y., Genina O., Volpin H., Bruck R., Spira G., Nagler A., Kawada N., Yoshizato K., Reinhardt D. P., Libermann T. A. and Pines M. (2007): Gene expression during chemically induced liver fibrosis: effect of halofuginone on TGF-beta signaling. Cell Tissue Res., 328, 153-166.
19. Hahn A. (2006): Differentielle Genexpression der Gene APR-1, B56, RGC32 und SIAT-8A bei kutanen T-Zell-Lymphomen. Ruprecht-Karls-Universität Heidelberg Fakultät für Klinische Medizin Mannheim, PhD Thesis, Mannheim, Heidelberg.
20. Horne D. T. and Vockley J. (2005): Gene expression profiles in liver cancer US Patent 6974667, Gene Logic, Inc, United Stated.
21. James E. R., Fresco V. M. and Robertson L. L. (2005): Glucocorticoid-induced changes in the global gene expression of lens epithelial cells. J. Ocul. Pharmacol. Ther., 21, 11-27.
22. Jo M. and Curry T. E. Jr. (2006): Luteinizing hormone-induced RUNX1 regulates the expression of genes in granulosa cells of rat periovulatory follicles. Mol. Endocrinol., 20, 2156-2172.
23. Jo M., Gieske M. C., Payne C. E., Wheeler-Price S. E., Gieske J. B., Ignatius I. V., Curry T. E. Jr. and Ko C. (2004): Development and application of a rat ovarian gene expression database. Endocrinology, 145, 5384-5396.
24. Kakiuchi S., Daigo Y., Tsunoda T., Yano S., Sone S. and Nakamura Y. (2003): Genome-wide analysis of organ-preferential metastasis of human small cell lung cancer in mice. Mol. Cancer Res., 1, 485-499.
25. Kang Y., Siegel P. M., Shu W., Drobnjak M., Kakonen S. M., Cordon-Cardo C., Guise T. A. and Massague J. (2003): A multigenic program mediating breast cancer metastasis to bone. Cancer Cell, 3, 537-549.
26. Katogi R., Nakatani Y., Shin-i T., Kohara Y., Inohaya K. and Kudo A. (2004): Large-scale analysis of the genes involved in fin regeneration and blastema formation in the medaka, Oryzias latipes. Mech. Dev., 121, 861-872.
27. Kyng K. J., May A., Kolvraa S. and Bohr V. A. (2003): Gene expression profiling in Werner syndrome closely resembles that of normal aging. Proc. Natl. Acad. Sci. USA, 100, 12259-12264.
28. Li F., Luo Z., Huang W., Lu Q., Wilcox C. S., Jose P. A. and Chen S. (2007): Response gene to complement 32, a novel regulator for transforming growth factor-beta-induced smooth muscle differentiation of neural crest cells. J. Biol. Chem., 282, 10133-10137.
29. Lim H. W., Lee J. E., Shin S. J., Lee Y. E., Oh S. H., Park J. Y., Seong J. K. and Park J. S. (2002): Identification of differentially expressed mRNA during pancreas regeneration of rat by mRNA differential display. Biochem. Biophys. Res. Commun., 299, 806-812.
30. Liu T. M., Martina M., Hutmacher D. W., Hui J. H., Lee E. H. and Lim B. (2007): Identification of common pathways mediating differentiation of bone marrow- and adipose tissue-derived human mesenchymal stem cells into three mesenchymal lineages. Stem Cells, 25, 750-760.
31. Niculescu F., Badea T. and Rus H. (1999): Sublytic C5b-9 induces proliferation of human aortic smooth muscle cells: role of mitogen activated protein kinase and phosphatidylinositol 3-kinase. Atherosclerosis, 142, 47-56.
32. Oram S. W., Liu X. X., Lee T. L., Chan W. Y. and Lau Y. F. (2006): TSPY potentiates cell proliferation and tumorigenesis by promoting cell cycle progression in HeLa and NIH3T3 cells. BMC Cancer, 6, 154.
33. Rasiah K. (2006): The Identification of Novel Biomarkers in the Development and Progression of Early Prostate Cancer, Cancer Research Program, Garvan Institute for Medical Research, Doctor of Philosophy, University of New South Wales, New South Wales, pp. 243.
34. Rieneck K., Bovin L. F., Josefsen K., Buschard K., Svenson M. and Bendtzen K. (2000): Massive parallel gene expression profiling of RINm5F pancreatic islet beta-cells stimulated with interleukin-1beta. APMIS, 108, 855-872.
35. Rozsa F. W., Reed D. M., Scott K. M., Pawar H., Moroi S. E., Kijek T. G., Krafchak C. M., Othman M. I., Vollrath D., Elner V. M. and Richards J. E. (2006): Gene expression profile of human trabecular meshwork cells in response to long-term dexamethasone exposure. Mol. Vis., 12, 125-141.
36. Rubio A., Guruceaga E., Vazquez-Chantada M., Sandoval J., Martinez-Cruz L. A., Segura V., Sevilla J. L., Podhorski A., Corrales F. J., Torres L., Rodriguez M., Aillet F., Ariz U., Arrieta F. M., Caballeria J., Martin-Duce A., Lu S. C., Martinez-Chantar M. L. and Mato J. M. (2007): Identification of a gene-pathway associated with non-alcoholic steatohepatitis. J. Hepatol., 46, 708-718.
37. Rus H. G., Niculescu F. and Shin M. L. (1996): Sublytic complement attack induces cell cycle in oligodendrocytes. J. Immunol., 156, 4892-4900.
38. Sagiv E., Memeo L., Karin A., Kazanov D., Jacob-Hirsch J., Mansukhani M., Rechavi G., Hibshoosh H. and Arber N. (2006): CD24 is a new oncogene, early at the multistep process of colorectal cancer carcinogenesis. Gastroenterology, 131, 630-639.
39. Saigusa K., Imoto I., Tanikawa C., Aoyagi M., Ohno K., Nakamura Y. and Inazawa J. (2007): RGC32, a novel p53-inducible gene, is located on centrosomes during mitosis and results in G2/M arrest. Oncogene, 26, 1110-1121.
40. Schwartz G. K. and Shah M. A. (2005): Targeting the cell cycle: a new approach to cancer therapy. J. Clin. Oncol., 23, 9408-9421.
41. Skottman H., Stromberg A. M., Matilainen E., Inzunza J., Hovatta O. and Lahesmaa R. (2006): Unique gene expression signature by human embryonic stem cells cultured under serum-free conditions correlates with their enhanced and prolonged growth in an undifferentiated stage. Stem Cells, 24, 151-167.
42. Smith M., Woodroffe A., Smith R., Holguin S., Martinez J., Filipek P. A., Modahl C., Moore B., Bocian M. E., Mays L., Laulhere T., Flodman P. and Spence M. A. (2002): Molecular genetic delineation of a deletion of chromosome 13q12->q13 in a patient with autism and auditory processing deficits. Cytogenet. Genome Res., 98, 233-239.
43. Souza V., Dong Y. B., Zhou H. S., Zacharias W. and McMasters K. M. (2005): SW-620 cells treated with topoisomerase I inhibitor SN-38: gene expression profiling. J. Transl. Med., 3, 44.
44. Strom C. C., Aplin M., Ploug T., Christoffersen T.E., Langfort J., Viese M., Galbo H., Haunso S. and Sheikh S. P. (2005): Expression profiling reveals differences in metabolic gene expression between exercise-induced cardiac effects and maladaptive cardiac hypertrophy. FEBS J., 272, 2684-2695.
45. Sung J., Turner J., McCarthy S., Enkemann S., Li C. G., Yan P., Huang T., Yeatman T. J. (2005): Oncogene regulation of tumor suppressor genes in tumorigenesis. Carcinogenesis, 26, 487-494.
46. Takai N., Kawamata N., Walsh C. S., Gery S., Desmond J. C., Whittaker S., Said J. W., Popoviciu L. M., Jones P. A., Miyakawa I. and Koeffler H. P. (2005): Discovery of epigenetically masked tumor suppressor genes in endometrial cancer. Mol. Cancer Res., 3, 261-269.
47. Takeda A., Goolsby C. and Yaseen N. R. (2006): NUP98-HOXA9 induces long-term proliferation and blocks differentiation of primary human CD34+ hematopoietic cells. Cancer Res., 66, 6628-6637.
48. Tan Y. J., Tham P. Y., Chan D. Z., Chou C. F., Shen S., Fielding B. C., Tan T. H., Lim S. G. and Hong W. (2005): The severe acute respiratory syndrome coronavirus 3a protein up-regulates expression of fibrinogen in lung epithelial cells. J. Virol., 79, 10083-10087.
49. Tanaka T., Takada H., Nomura A., Ohga S., Shibata R. and Hara T. (2005): Distinct gene expression patterns of peripheral blood cells in hyper-IgE syndrome. Clin. Exp. Immunol., 140, 524-531.
50. Taylor M. W., Grosse W. M., Schaley J. E., Sanda C., Wu X., Chien S. C., Smith F., Wu T. G., Stephens M., Ferris M. W., McClintick J. N., Jerome R. E. and Edenberg H. J. (2004): Global effect of PEG-IFN-alpha and ribavirin on gene expression in PBMC in vitro. J. Interferon Cytokine Res., 24, 107-118.
51. Viemann D., Goebeler M., Schmid S., Klimmek K., Sorg C., Ludwig S. and Roth J. (2004): Transcriptional profiling of IKK2/NF-kappa B- and p38 MAP kinase-dependent gene expression in TNF-alpha-stimulated primary human endothelial cells. Blood, 103, 3365-3373.
52. Wang S. F., Liang Q., Li G. W. and Gao K. (2005): Gene expression profile in rat small intestinal allografts after cold preservation/reperfusion. World J. Gastroenterol., 11, 885-889.
53. Yudt M. R., Berrodin T. J., Jelinsky S. A., Hanna L. A., Brown E. L., Chippari S., Bhat R. A., Winneker R. C. and Zhang Z. (2006): Selective and opposing actions of progesterone receptor isoforms in human endometrial stromal cells. Mol. Cell Endocrinol., 247, 116-126.
54. Zhan F., Huang Y., Colla S., Stewart J. P., Hanamura I., Gupta S., Epstein J., Yaccoby S., Sawyer J., Burington B., Anaissie E., Hollmig K., Pineda-Roman M., Tricot G., van Rhee F., Walker R., Zangari M., Crowley J., Barlogie B. and Shaughnessy J. D. Jr. (2006): The molecular classification of multiple myeloma. Blood, 108, 2020-2028.